Cimetidine
Who holds supplier records for Cimetidine? 3 organisations hold a current record for Cimetidine: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Spain (1), India (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cimetidine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cimetidine
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cimetidine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)SpainCEPActive DMF 10982 · latest filing Jul 1994
- SMS LIFESCIENCES INDIA LTDIndiaActive DMF 40873 · latest filing Dec 2024
- Jiangsu Zenji Pharmaceuticals LTD.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (2)
Certificates of Suitability on the EDQM register for Cimetidine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| JIANGSU ZENJI PHARMACEUTICALS LTD. Huai'an City | CN | R0-CEP 2020-301 - Rev 00 Cimetidine | Jun 2023 | — |
| Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona | ES | R1-CEP 1998-023 - Rev 06 Cimetidine | Sept 2019 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (13)
Organisations whose Type II DMFs for Cimetidine are no longer active. These show a past filing, not current supply.
Show all 13 historical records
- WUXI KAILI PHARMACEUTICAL CO LTDInactive DMF 12263 · filed Sept 1996
- SMITHKLINE BEECHAM PHARMACEUTICALSInactive DMF 11805 · filed Jan 1996
- LABORATORIO BP SRLInactive DMF 10029 · filed Jan 1993
- Hungary · Inactive DMF 9637 · filed Apr 1992
- FIRST SOUTHWEST PHARMACEUTICAL FACTORYInactive DMF 8984 · filed Feb 1991
- IND ESQUIMEX SA KM 396 CARRETERA MEXInactive DMF 8536 · filed Apr 1990
- Spain · Inactive DMF 8417 · filed Jan 1990
- 1ST SOUTHWEST PHARMACEUTICAL FACTORYInactive DMF 8345 · filed Dec 1989
- APOTEX PHARMACHEM INCInactive DMF 8021 · filed Apr 1989
- SHANGHAI NO 6 PHARMACEUTICAL FACTORYInactive DMF 7541 · filed Jun 1988
- Italy · Inactive DMF 5497 · filed Jul 1984
- SMITHKLINE AND BECKMAN INCInactive DMF 5123 · filed Sept 1983
- SYNTEX USA INCInactive DMF 2991 · filed Aug 1977
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Cimetidine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is commonly used in the treatment of heartburn and peptic ulcers.
Chemical identity
- IUPAC name
- 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
- Canonical SMILES
- CC1=C(N=CN1)CSCCNC(=NC)NC#N
- InChIKey
- AQIXAKUUQRKLND-UHFFFAOYSA-N
- Synonyms
- Tagamet API, cimetidine, Acinil, Ulcedin, Eureceptor, Gastromet, Tametin, Ulcimet, Dyspamet, Ulcomedina, Cimal, Acibilin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Histamine-2 Receptor Antagonist
- Mechanism of action
- Histamine H2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cimetidine?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Cimetidine: UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (Spain), SMS LIFESCIENCES INDIA LTD (India) and Jiangsu Zenji Pharmaceuticals LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cimetidine Drug Master Files are active?
UNION QUIMICO FARMACEUTICA SA (UQUIFA SA) (DMF 10982) and SMS LIFESCIENCES INDIA LTD (DMF 40873). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cimetidine records mean?
13 organisations have only inactive Type II DMFs for Cimetidine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cimetidine have a European Certificate of Suitability?
Yes. 2 organisations hold a valid CEP for Cimetidine on the EDQM register, including JIANGSU ZENJI PHARMACEUTICALS LTD. Huai'an City (CN) and Union Quimico Farmaceutica, S.A. (Uquifa S.A.) Barcelona (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Cimetidine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cimetidine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.